This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc.. Active years: 2026.
Company Filing History:
2 out of 823 
2 out of 2 Years Active: 2026
Title: George Topalov: Innovator in Pharmaceutical Compounds
Introduction
George Topalov is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrocyclic compounds. With a total of 2 patents, his work has the potential to impact various therapeutic areas.
Latest Patents
Topalov's latest patents include innovative disclosures related to macrocyclic compounds, compositions, and methods of using them. These patents focus on CFTR modulators, pharmaceutical compositions, and methods for making and utilizing these compounds effectively. His research aims to enhance the treatment options available for patients.
Career Highlights
Throughout his career, George Topalov has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Genzyme Corporation and Sionna Therapeutics Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Arielle Genevois Borella and Michael Kothe. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
George Topalov's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.